SomaScan™ 11K Assay is now Illumina SomaScan Discovery. Learn more.

Developing microbiome-directed therapeutics for treating childhood undernutrition

Developing microbiome-directed therapeutics for treating childhood undernutrition

Abstract

This 1-hour talk covers how researchers are testing the hypothesis that perturbations in the normal development of the gut microbiome are causally related to childhood undernutrition, a devastating global health problem whose long-term sequelae include metabolic and immune dysfunction, stunting, and neurodevelopmental abnormalities, which remains largely refractory to current therapeutic interventions.

Learning objectives

This 1-hour talk covers how researchers are testing the hypothesis that perturbations in the normal development of the gut microbiome are causally related to childhood undernutrition, a devastating global health problem whose long-term sequelae include metabolic and immune dysfunction, stunting, and neurodevelopmental abnormalities, which remains largely refractory to current therapeutic interventions.

  • Understand evidence that impaired postnatal development of the gut microbiota is causally related to childhood undernutrition
  • Understand how preclinical gnotobiotic animal models can be used to develop new microbiota-directed therapeutics
  • Understand how multiomic methods, including SomaScan® Assay proteomics, can be used to judge the efficacy and mechanism of action of these therapeutics in clinical studies

JG-picture-1-300x300-1

Jeffrey Gordon, MD

Director, Edison Family Center for Genome Sciences and Systems Biology, Washington University

MB-picture-1-300x300-1

Michael J. Barratt, PhD

Executive Director, Center for Gut Microbiome and Nutrition Research, Washington University

 

Developing microbiome-directed therapeutics for treating childhood undernutrition

A webinar presented by Jeffrey Gordon, MD, and Michael J. Barratt, PhD

Request more information

Contact us

Share with colleagues

More webinars

WebinarOpening the black box: Building and evaluating machine learning models for proteomics

Machine learning can be a powerful way to extract multivariate signals from high-dimensional proteomics data, but only when models are built and evaluated with rigor. In this on-demand webinar, explore a practical framework for developing predictive and explanatory models, with an emphasis on study design choices that help prevent data leakage, reduce overfitting, and improve reproducibility.

Learn more

WebinarBeyond the trees: See the bigger biological picture with pathway enrichment analysis

Proteomic data holds enormous potential—but the biology is rarely contained in a single protein. When you’re handed a list of differentially abundant proteins, the next challenge is turning that list into a clear, testable story about mechanisms and processes.

Learn more

WebinarFinding the signal: Identifying reproducible biomarkers in high-plex proteomics

In biomarker discovery, the challenge is rarely a lack of data. Rather, it is knowing how to separate meaningful biological signal from technical distraction. This webinar focuses on how to use univariate analysis as a practical and powerful entry point for biomarker discovery in high-plex proteomics studies.

Learn more

Explore webinars in our interactive viewer